Longeveron Inc. SEC filings LGVN

Longeveron Inc. has 532 filings in SEC EDGAR's recent list, going back to Nov 6, 2017. Its latest annual report, Form ARS, was filed on May 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders May 20, 2026 Dec 31, 2025
10-K Annual report Mar 17, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
10-K Annual report Feb 28, 2025 Dec 31, 2024
ARS Annual report to shareholders May 20, 2024 Dec 31, 2023
10-K/A Amended annual report Mar 11, 2024 Dec 31, 2023
10-K Annual report Feb 27, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
10-K Annual report Mar 14, 2023 Dec 31, 2022
10-K Annual report Mar 11, 2022 Dec 31, 2021
10-K/A Amended annual report Apr 9, 2021 Dec 31, 2020
10-K Annual report Mar 30, 2021 Dec 31, 2020

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LGVN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Miami, FL
SEC filer status
, Emerging growth company
SEC CIK
1721484
Former names
LONGEVERON LLC (until Feb 10, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.